Abstract:Background Acute respiratory distress syndrome (ARDS) is characterized by sudden and extensive pulmonary inflammation, with a mortality rate of approximately 40%. Presently, there is no effective treatment to prevent or reverse its severe consequences. Baicalein (BAI) is a natural vicinal trihydroxyflavone and has been identified as the core quality marker of Scutellariae baicalensis for its effect on lung inflammation. However, its oral bioavailability is limited. The majority of studies that investigate BAI's in vivo mechanisms use injection techniques. Currently, there is no clear understanding of the mechanisms by which low-bioavailable BAI functions orally. Purpose This study aimed to evaluate the efficiency of BAI in ARDS mice and its underlying mechanisms. Study design and methods Behavioral experiments, histological analysis, immunofluorescence staining, flow cytometry of immune cells, qRT-PCR, and ELISA analysis were performed to evaluate the efficiency of BAI in ARDS mice. Lung tissues transcriptomic-based analyses were performed to detect the differentially expressed genes and biological pathways. Fecal samples were subjected to microbial 16S rRNA analysis and untargeted metabolomics analysis in order to identify the specific flora and metabolites associated with BAI. Furthermore, antibiotic cocktail treatment and fecal microbiota transplantation were used to elucidate the gut microbiota-mediated effects on ARDS. Results In our study, we first find that oral administration of BAI effectively mitigates staphylococcal enterotoxin B-induced ARDS. BAI can alleviate gut dysbiosis and regulate the Toll-like signaling pathway and amino acid metabolism. The protective effects of BAI against ARDS are gut microbiota dependent. Modulation of gut microbiota increases the production of short-chain fatty acids and enhances lung barrier function, which is consistent with the therapeutic interventions with BAI. Notably, BAI greatly enriches the abundance of Prevotellaceae , a butyrate-producing bacterial family, exhibiting a positive correlation with key differentially expressed genes in the TLR4/MyD88 signaling cascades. Conclusion BAI emerges as a potential prebiotic agent to attenuate ARDS, and targeting specific microbial species may offer an innovative therapeutic approach to investigate other flavonoids with limited bioavailability.

Baicalein ameliorates SEB-induced acute respiratory distress syndrome in a microbiota-dependent manner

Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats

Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice Via Inhibiting TLR4/JNK/ERK/NF-κB Pathway

Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Inhibiting TLR4/JNK/ERK/NF- κ B Pathway

Wine-processed radix scutellariae alleviates ARDS by regulating tryptophan metabolism through gut microbiota

Baicalein suppresses inflammation and attenuates acute lung injury by inhibiting glycolysis via HIF‐1α signaling

Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF‑κB signaling pathway

Baicalin ameliorates multidrug-resistant Pseudomonas aeruginosa induced pulmonary inflammation in rat via arginine biosynthesis

Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s

Effect of Baicalin on Inflammatory Mediator Levels and Microcirculation Disturbance in Rats with Severe Acute Pancreatitis

Effects of Baicalin on Pulmonary Functions of Acute Respiratory Distress Syndrome Induced by Oleic Acid in Rats

Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury

Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro

Baicalin alleviates acute lung injury in vivo and in vitro

Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis

Baicalin inhibits APEC-induced lung injury by regulating gut microbiota and SCFA production

Baicalein alleviates tubular-interstitial nephritis in vivo and in vitro by down-regulating NF-κB and MAPK pathways

Baicalein Attenuates OVA-induced Allergic Airway Inflammation Through the Inhibition of the NF-κB Signaling Pathway

Baicalein suppresses lipopolysaccharide-induced acute lung injury by regulating Drp1-dependent mitochondrial fission of macrophages

Effect of Baicalin on Rat Cardiac Function During Acute Respiratory Distress Syndrome

Baicalein attenuates the neuroinflammation in LPS-activated BV-2 microglial cells through suppression of pro-inflammatory cytokines, COX2/NF-κB expressions and regulation of metabolic abnormality